Prime Focus Technologies expands Southeast Asia presence with strategic partnerships in Indonesia and the Philippines

Prime Focus Technologies expands Southeast Asia presence with strategic partnerships in Indonesia and the Philippines

LOS ANGELES, May 22, 2025 /PRNewswire/ -- Prime Focus Technologies (PFT), the creator of CLEAR®, has entered strategic partnerships with Interindo Multimedia in Indonesia and Challenge Systems in the Philippines. These collaborations mark a...

CCTV+: Bangkok Hosts China (Guizhou) – Thailand Cultural and Tourism Business Meeting, Highlights New International Partnership Opportunities

CCTV+: Bangkok Hosts China (Guizhou) – Thailand Cultural and Tourism Business Meeting, Highlights New International Partnership Opportunities

BEIJING, May 19, 2025 /PRNewswire/ -- At the China (Guizhou) - Thailand Cultural and Tourism Business Meeting held in Bangkok on May 16, regional officials and stakeholders from both Guizhou Province and the Kingdom of Thailand engaged in formal...

Dogness Announces Entry into US$6.0 Million Private Placement

Dogness Announces Entry into US$6.0 Million Private Placement

DONGGUAN, China and PLANO, Texas, May 9, 2025 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet...

Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain for Mexico

Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain for Mexico

TAIPEI, May 7, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights in Mexico for the...

Quhuo Reports Financial Results for the Second Half and Full Year 2024

Quhuo Reports Financial Results for the Second Half and Full Year 2024

BEIJING, April 29, 2025 /PRNewswire/ -- Quhuo Limited (Nasdaq: QH) ("Quhuo," the "Company," "we" or "our"), a leading gig economy platform focusing on local life services in China, today reported its unaudited financial results for the six months...

Sonitus Medical and BHM Establish Strategic Cooperation

Sonitus Medical and BHM Establish Strategic Cooperation

SHANGHAI, April 28, 2025 /PRNewswire/ -- Sonitus Medical has entered into a strategic cooperation with BHM, a renowned European manufacturer of bone conduction hearing devices. The two companies will engage in deep collaboration across product...

GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY

GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY

HO CHI MINH CITY, April 22, 2025 /PRNewswire/ -- Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a company democratizing access to advanced life science solutions, have...

AB Crosses the Singularity: Building a New Generation of Secure and Scalable Infrastructure for Decentralized Applications and Assets

AB Crosses the Singularity: Building a New Generation of Secure and Scalable Infrastructure for Decentralized Applications and Assets

SINGAPORE, April 8, 2025 /PRNewswire/ -- In early April, at a bustling Web3 gathering in Hong Kong, a crypto investor from Dubai named Ahmed shared a story that captured the attention of the room. "When I recovered my three-year-old BEP2 tokens...

TCTM Announces Entering into An Intangible Asset Purchase Agreement

TCTM Announces Entering into An Intangible Asset Purchase Agreement

BEIJING, April 7, 2025 /PRNewswire/ -- TCTM Kids IT Education Inc. (NASDAQ: TCTM) ("TCTM" or the "Company"), a leading provider of IT-focused supplementary STEM education services in China, today announced that it has entered into an intangible...

Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

Key Highlights: Global first "immuno + anti-vascular" bispecific antibody approved: ivonescimab for EGFR-TKI resistant nsq-NSCLC. Phase III HARMONi study topline data expected mid-2025 (FDA FTD). ivonescimab outperforms pembrolizumab in Phase III...

  • 1
  • 2
  • 3
  • 4
  • 5
  • menu
    menu